article thumbnail

PET predicts adverse events in heart disease patients

AuntMinnie

PET imaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. Patients underwent the scans between January 2017 and January 2021. The full study is available here.

Disease 110
article thumbnail

CT-defined CAC predicts cardiovascular events in lung cancer patients

AuntMinnie

"[We found] a meaningful impact of the CAC score on overall survival and [that it] was associated with the occurrence of major cardiovascular events," wrote a team led by Hans-Jonas Meyer of the University of Leipzig in Germany. CAC can be quantified by CT imaging and is an important predictor for cardiovascular disease, the team explained.

Disease 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PET/CT predicts adverse cardiac events in men with prostate cancer

AuntMinnie

PET/CT scans used to visualize findings in men with recurrent prostate cancer may also help assess their risk for cardiovascular disease, according to a study published January 22 in Clinical Genitourinary Cancer. Cardiovascular disease (CV) is common among men with prostate cancer and the leading cause of death in this population.

Disease 115
article thumbnail

Interstitial lung abnormalities linked to respiratory disease risk

AuntMinnie

CT imaging shows that severe acute respiratory disease events can be caused by quantitative interstitial abnormalities (QIA) -- that is, small irregularities that don't necessarily meet diagnostic criteria for advanced pulmonary diseases but show up on CT exams over time, a study published April 30 in Radiology has reported.

Disease 111
article thumbnail

Beware risk of adverse events associated with GBCAs

AuntMinnie

To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang , PhD, of Yantai Yuhuangding Hospital in Yantai, China. Food and Drug Administration (FDA) approved the first GBCA in 1998, and ever since, this class of drugs has been used with MRI to diagnose disease.

Education 105
article thumbnail

AI-Enhanced Technology Predicts Fatal and Non-Fatal Cardiac Events from Routine CCTA

MedImaging Ultrasound

An innovative AI technology that can predict both fatal and non-fatal cardiac events has the potential to revolutionize the way coronary artery disease is treated by transforming the risk evaluation and management of patients who undergo routine CCTA.

Disease 96
article thumbnail

AI-enhanced cardiac CT could help curb cardiovascular events

AuntMinnie

The FAI score is one way to capture inflammatory risk beyond the current clinical risk stratification and CCTA interpretation, particularly among patients without obstructive [coronary artery disease], according to Chan, Antoniades, and colleagues. Certain applications are progressing faster than others, however.

Disease 105